Exoskeleton Partial‐Coated Stem Cells for Infarcted Myocardium Restoring

Abstract

The integration of abiotic materials with live cells has emerged as an exciting strategy for the control of cellular functions. Exoskeleton consisting of metal‐organic frameworks (MOFs) are generated to produce partial‐coated bone marrow stem cells (BMSCs) to overcome low cell survival leading to disappointing effects for cell‐based cardiac therapy. Partially coated exoskeletons can promote the survival of suspended BMSCs by integrating the support of exoskeletons and unimpaired cellular properties. In addition, partial exoskeletons exhibit protective effects against detrimental environmental conditions, including ROS (Reactive oxygen species), pH changes, and osmotic pressure. The partial‐coated cells exhibit increased intercellular adhesion forces to aggregate and adhere, promoting cell survival and preventing cell escape during cell therapy. The exoskeletons interact with cell surface receptors integrin α5β1, leading to augmented biological functions with profitable gene expression alteration, such as Vegfa, Cxcl12, and Adm. The partial‐coated BMSCs display enhanced cell retention in infarcted myocardium through non‐invasive intravenous injections. The repair of myocardial infarction has been achieved with improved cardiac function, myocardial angiogenesis, proliferation, and inhibition of cell apoptosis. This discovery advances the elucidation of potential molecular and cellular mechanisms for cell‐exoskeleton interactions and benefits the rational design and manufacture of next‐generation nanobiohybrids.This article is protected by copyright. All rights reserved